Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution recall: Sterility Concern
Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355…
Why was Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution recalled?
Lack of Assurance of Sterility
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 67808, Exp. Date 10/23/2023
- Product
- Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355…
- Recalling firm
- Pine Pharmaceuticals, LLC
- Quantity
- 860 syringes
- Distribution
- Nationwide within the United States
- Recall date
- October 25, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)